Huge gene study finds 48 new Alzheimer’s clues, opening doors for dementia research

The map scientists use to hunt for dementia treatments just got much bigger. Researchers found 48 new spots in our DNA linked to Alzheimer’s disease, and many point to the brain’s own immune cells.

You can’t change your genes, and you don’t need to. Each new spot is a new place for drug developers to look, and that is how real progress starts.

How the study worked

An international team combined genetic data from people of many ancestries: those with Alzheimer’s, those without it, and “proxy” cases, meaning people whose parent had the disease. In all, it covered more than 2 million people. It was published Oct. 28, 2026, in Nature. The study shows where risk sits in the genome, and the next job is working out how each gene does its work.

What they found

Until now, only about 80 genetic regions had been firmly tied to Alzheimer’s. This study found 118 regions in a combined analysis of all ancestries. It found 9 more in analyses of specific ancestries. Of these, 48 are new.

The team also named new risk genes and picked out some that could become drug targets.

The clues came together on two kinds of brain cells. Genes that were more active in microglia, the brain’s immune cells, and less active in neurons in people with Alzheimer’s carried extra genetic risk. That fits a picture where the brain’s cleanup and defense system plays a central role.

The study also changed a big number. Researchers had thought common gene variants explained only a small slice of Alzheimer’s risk. This study estimated 16%, nearly three times higher than earlier estimates. The team also improved “polygenic prediction,” which means combining many small gene differences into one risk score.

In plain words: the common DNA differences that shape dementia risk matter more than scientists believed, and there are many more of them to study.

Why does it matter that there is so much “hidden” genetics?

Twin studies have long suggested that 60-80% of Alzheimer’s risk comes from genes. Yet the known gene regions explained only a small part of that. Researchers even wondered whether much more was left to find.

Now they know there is. More known regions means more ways to understand what goes wrong in the brain, and more targets for medicines that someone can design and test.

What you can do today

Genes are one part of the story. A large share of dementia risk is linked to things you can influence, such as blood pressure, hearing, physical activity and smoking. And knowing your family history helps your doctor look at the full picture.

Take two minutes today to write down whether any close relatives had dementia and at what age. Add your latest blood pressure reading from the pharmacy kiosk or your last checkup. Keep the note where you’ll find it and bring it to your next visit.